Lundbeck has secured FDA Fast Track designation for Lu AH69593, an oral orexin 2 receptor agonist being developed for...
Lire la suiteNICE has issued final draft guidance recommending Bayer’s finerenone for adults with symptomatic chronic heart failure and a left...
Lire la suiteThe Regen4HD study has launched the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for...
Lire la suiteNovartis has secured European Commission approval for Itvisma, a one-time gene replacement therapy for a broad group of patients...
Lire la suiteAgomab Therapeutics is preparing to begin dosing patients in its phase 2b NOV-ERA study of ontunisertib for fibrostenosing Crohn’s...
Lire la suiteTeva Pharmaceutical Industries has submitted a New Drug Application to the U.S. Food and Drug Administration for ecopipam, an...
Lire la suite